Fundraising Fox

Ruchita Sinha

Investor

General Partner at AV8 Ventures

San Francisco Bay Area

Writes $500K – $5M checks · typically $2M

FoundedBrave Care · YC

About

Ruchita Sinha combines deep cellular and molecular biology training with an MBA in finance and Sanofi‑Genzyme BioVentures leadership experience to offer technical, pharma-focused guidance on company and clinical program design.

Invests in

AI & Machine LearningBiotechDigital HealthEnterprise SoftwareFintechHealthtechInsurTech

Experience

  1. ARTIS VenturesSenior Partnercurrent2025 — present
  2. AV8 VenturesVenture Partnercurrent2019 — presentSan Francisco Bay Area
  3. SanofiSr. Director of Investments2016 — 2019
  4. GE VenturesDirector, GE Ventures2013 — 2016Menlo Park, CA
  5. Pfizer PharmaceuticalsDirector, Strategy, Portfolio Management, and Commercial Operations2010 — 2013Greater New York City Area
  6. L.E.K. ConsultingSr. Consultant2007 — 2010Greater New York City Area
  7. MaxygenResearch Associate2001 — 2005San Francisco Bay Area

Education

  1. The University of Chicago Booth School of BusinessMBA, Finance and Entreprenuership2005 — 2007
  2. University of Wisconsin-MadisonMaster of Science - MS, Cell/Cellular and Molecular Biology
  3. Mount Holyoke CollegeBS, Biochemistry

Skills & more

Business Strategy23Venture Capital10Mergers1Business Development9Marketing Strategy2Cross-functional Team Leadership24Biotechnology8Management Consulting2LifesciencesCorporate Development1Due Diligence2Valuation
+12 moreFinancial ModelingProduct DevelopmentCompetitive AnalysisStart-upsMarket AnalysisTechnology TransferMergers & AcquisitionsMedical DevicesStrategyStrategic PlanningPharmaceutical IndustryLife Sciences

From Ruchita's professional profile.

Same school

Shared employers

Investments

Investor

AetionClick TherapeuticsCommon SensingCurisiumEvidation HealthInozymeOmada HealthScience 37

Per the firm's website.

Colleagues at AV8 Ventures

Network1

Investors connected to Ruchita in public investor directories — a warm-intro map.